关键词：鼻内药物；治疗；局部疾病；过敏性；非过敏性鼻炎；鼻窦炎
摘 要：Intranasal drug delivery is used to treat local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous advances in technology in intranasal drug delivery products help achieve efficient treatment. Intranasal drug delivery systems provide an easy mode of administration for patients on long-term therapy, avoid risk of overdose, and enhance the bioavailability of the drug.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.1.1 Market Size and Forecast

06.2 Five Forces Analysis

07. Market Segmentation by Product

07.1 Global Intranasal Drug Delivery Market by

Product 2013-2018

08. Geographical Segmentation

08.1 Global Intranasal Drug Delivery Market by

Geographical Segmentation 2013-2018

08.1.1 Market Size and Forecast

08.2 Intranasal Drug Delivery Market in the Americas

08.2.1 Market Size and Forecast

08.3 Intranasal Drug Delivery Market in the EMEA

Region

08.3.1 Market Size and Forecast

08.4 Intranasal Drug Delivery Market in the APAC

Region

08.4.1 Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.2 Market Share Analysis 2013

16.3 Other Prominent Vendors

17. Key Vendor Analysis

17.1 Becton Dickinson

17.1.1 Key Facts

17.1.2 Business Description

17.1.3 Business Segmentation

17.1.4 Revenue Segmentation by Business

17.1.5 Segmental Revenue Comparison - 2013 and 2012

17.1.6 Revenue Segmentation by Geography

17.1.7 Business Strategy

17.1.8 Key Developments

17.1.9 SWOT Analysis

17.1.10 Strengths

17.1.11 Weakness

17.1.12 Opportunities

17.1.13 Threats

17.2 GlaxoSmithKline

17.2.1 Key Facts

17.2.2 Business Overview

17.2.3 Business Segmentation

17.2.4 Business Segmentation by Revenue 2012 and 2013

17.2.5 Sales by Geography

17.2.6 Pipeline Products

17.2.7 Business Strategy

17.2.8 Key Information

17.2.9 SWOT Analysis

17.2.10 Strengths

17.2.11 Weaknesses

17.2.12 Opportunities

17.2.13 Threats

17.3 Johnson & Johnson

17.3.1 Key Facts

17.3.2 Business Overview

17.3.3 Business Segmentation by Revenue 2013

17.3.4 Business Segmentation by Revenue 2012 and 2013

17.3.5 Geographical Segmentation by Revenue 2013

17.3.6 Business Strategy

17.3.7 Recent Developments

17.3.8 SWOT Analysis

17.3.9 Strengths

17.3.10 Weaknesses

17.3.11 Opportunities

17.3.12 Threats

17.4 Novartis

17.4.1 Key Facts

17.4.2 Business Overview

17.4.3 Business Segmentation by Revenue 2013

17.4.4 Business Segmentation by Revenue 2012 and 2013

17.4.5 Sales by Geography

17.4.6 Business Strategy

17.4.7 Key Developments

17.4.8 SWOT Analysis

17.4.9 Strengths

17.4.10 Weaknesses

17.4.11 Opportunities

17.4.12 Threats